You are currently viewing Nintedanib Impurities Now Available Ready Stock At Toref

Nintedanib Impurities Now Available Ready Stock At Toref

  • Post category:Blogs
  • Post comments:0评论

Nintedanib is a drug that has been approved by the FDA for some types of Interstitial lung disease (ILD) which have symptoms of shortness of breath, a dry cough, feeling tired and chest discomfort.  It is used for types of ILD that cause scarring in the lungs such as idiopathic pulmonary fibrosis (IPF), certain chronic fibrosing interstitial lung diseases (ILDs) and nintedanib helps lung function in people with systemic sclerosis-associated interstitial lung disease.

Nintedanib belongs to a class of drugs known as tyrosine kinase inhibitors, which work by inhibiting specific enzymes involved in the growth and spread of cancer cells or fibrotic tissue.

Removal of impurity standards from API manufacturing is an integral part of drug manufacturing. Toref has specialization in synthesis / supply of pharmacopoeia impurities, process impurities, isolation and identification of unknown impurities of Nintedanib to all pharmaceutical companies globally. All ready-to-ship Nintedanib Impurities are tabulated below:

Product NameCAS No.Molecular Formula
Nintedanib Impurity D708223-17-0C10H10ClNO3
Nintedanib Impurity E91133-96-9C11H13NO4
Nintedanib Impurity CN/AC22H27N5O5
Nintedanib Impurity B1642584-53-9C10H9NO6
Nintedanib Impurity 58N/AC14H15NO6
Nintedanib Impurity FN/AC12H13NO5
Nintedanib Impurity GN/AC24H31N5O4

Contact us now for instant quote. We can provide you with research material for nealy every pharmaceutical impurity you want!